← FDA DRUG APPROVALS

FDA ANDA · ANDA062826

CEPHALEXIN

Sponsor: BARR

APPLICATION
ANDA062826
TYPE
ANDA
ORIGINAL APPROVAL
1987-08-17
LATEST ACTION
1998-12-01
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

CEPHALEXINDiscontinued
CEPHALEXIN EQ 250MG BASE · TABLET · ORAL

Approval history

1998-12-01Manufacturing (CMC) · Supplement 12AP
1997-04-01Labeling · Supplement 11AP
1995-12-15Manufacturing (CMC) · Supplement 10AP
1994-12-23Manufacturing (CMC) · Supplement 9AP
1993-10-15Labeling · Supplement 8AP
1992-04-03Manufacturing (CMC) · Supplement 7AP
1992-04-03Manufacturing (CMC) · Supplement 5AP
1989-03-08Manufacturing (CMC) · Supplement 4AP
1987-08-17OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →